Merck & Company vs UnitedHealth Group Incorporated at a glance
Both companies operate in the Health Care sector, so these figures are broadly like-for-like.
| Metric | MRK | UNH |
|---|---|---|
| Market cap | $366.72B | $356.01B |
| Price | $148.35 | $392.95 |
| P/E ratio (TTM) | 14.18 | 24.76 |
| P/B ratio (MRQ) | 4.92 | 3.17 |
| P/S ratio (TTM) | 3.98 | 0.67 |
| Revenue growth (1Y) | 1.31% | 11.81% |
| Return on equity (TTM) | 34.70% | 12.81% |
| Return on invested capital (TTM) | 22.71% | 9.58% |
| Gross margin (TTM) | 82.44% | 22.49% |
| Net margin (TTM) | 13.59% | 3.14% |
| Dividend yield (TTM) | 2.29% | 2.36% |
How they differ
Merck & Company is the larger company at $366.72B versus $356.01B, making them close in size.
On trailing earnings, Merck & Company is the cheaper of the two at 14.18 against 24.76 for UnitedHealth Group Incorporated.
On sales, UnitedHealth Group Incorporated is the cheaper of the two at 0.67 against 3.98 for Merck & Company.
UnitedHealth Group Incorporated leads on revenue growth over the past year, 11.81% against 1.31%.
Merck & Company leads on return on invested capital, 22.71% against 9.58%.
Merck & Company leads on gross margin, 82.44% against 22.49%.
UnitedHealth Group Incorporated offers the higher yield at 2.36% against 2.29%.
Go deeper
Ratios describe the past. Whether either is worth owning depends on what you pay today.
Related comparisons
Other matchups involving Merck & Company or UnitedHealth Group Incorporated.